BAYN News and Press, Bay National Corp

NORTHAMPTON, MA / ACCESSWIRE / August 29, 2023 / Bayer - As climate change quickens, societal expectations increase and the threat of resistance grows, new crop protection solutions are imperative. Advances in the life sciences and data-driven technologies hold the key to expanding our pipeline ...

Summary VanEck Natural Resources ETF tracks an index of hard asset firms. HAP has a global portfolio with holdings across six continents. The fund invests in companies that generate at least half their revenue from hard assets including agriculture, alternatives, base/industrial met...

Stocks finished the year strongly with cyclicals and energy stocks rallying strongly. I am continuing my monthly investment plans and suspiciously follow the massive rally in technology stocks as well as the vaccine-driven rebound in value stocks. My dividend income amounted to $3...

Because the animal-health industry is essential for livestock-based agriculture across the globe, demand for animal-health products is both reliable and growing. This makes animal-health companies a great way to round out a balanced healthcare portfolio with stocks that don't face the same set...

Quick Take Phathom Pharmaceuticals ( PHAT ) intends to raise $150 million from an IPO, per an S-1/A registration statement . The company is advancing a drug treatment for GERD, a common gastrointestinal condition. For life science investors with at least a 24-month hold timeframe, the I...

Quick Take Dragon Jade International ( OTCQX:DGJI ) has filed to raise gross proceeds of $10 million from a U.S. IPO, according to an F1/A registration statement . The firm has two lines of business - one that produces and distributes Chinese health supplements as well as one that engages...

Quick Take ADC Therapeutics ( ADCT ) intends to raise $200 million in an IPO of its common shares, per an F-1/A registration statement . The company is developing a pipeline of drug treatment candidates for various blood cancers and solid tumors. ADCT has shown promising trial results a...

Quick Take ADC Therapeutics ( ADCT ) has filed to raise gross proceeds of up to $150 million from a U.S. IPO, according to an F-1 registration statement . The firm is developing targeted antibody drug conjugates [ADCs] for the treatment of hematological malignancies and solid tumors. AD...

Quick Take Akero Therapeutics ( AKRO ) has filed to raise gross proceeds of $75.0 million from a U.S. IPO, according to an S-1/A registration statement . The firm is developing a treatment for metabolic diseases with high unmet clinical needs, with an initial focus on non-alcoholic steato...

NEW YORK , June 5, 2019 /PRNewswire/ --   OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lists of downgrades from its respective OTCQX® and OTCQB® markets and Caveat Emptor Desig...